Wu answered them in a new report, out today. The numbers are important here because they point to two questions underlying the whole strategy.
One big problem is numbers: The FDA is still waiting on more data from vaccine makers, as well as some from Israel, where research on fading immunity spooked American officials into pushing for boosters in the first place. Now, according to a New York Times report, health officials are advising the White House to rethink its plan. But the CDC advisory committee tasked with recommending how Americans use the vaccines never gave the green light. Last month, President Joe Biden set a mid-September launch goal for mRNA boosters, to be distributed eight months after the second shot for most American adults. Your COVID-19 booster shot might’ve just gotten bumped back a bit.
